Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The effectiveness of Dewandaru (Eugenia uniflora l.) Leaf crude extract on immunoglobulin E level in Wistar rats with allergic rhinitis

Sari Wulan Dwi Sutanegara, U Tei Dominica Fredlina.




Abstract
Cited by 0 Articles

Background: Dewandaru plant (Eugenia uniflora L.) is a plant that contains flavonoids with anti-inflammatory, anti-allergy and antioxidant effects that have various clinically proven benefits.
Aims: To determine the effectiveness of Dewandaru (Eugenia uniflora L.) leaf crude extract on total IgE levels in Wistar rats with ovalbumin-induced allergic rhinitis.
Methods: This is a true experimental study with a randomized post-test-only control group design. This study used 28 male Wistar rats randomly divided into 4 groups (n=7 in each group), i.e. negative control group (without therapy), 100 mg/kg BW in extract group, 200 mg/kg BW in extract group, and positive control group (mometasone furoate). Rats were sensitized with ovalbumin intraperitoneally for 14 days, followed by intranasal ovalbumin exposure on the 15th day for 14 days with intervention. Nasal symptom scores and IgE serum levels were assessed in all groups.
Results: There were significant differences in nasal symptoms scores between groups. Nasal symptom scores were significantly lower in the positive control group and treatment group than in the negative control group (p

Key words: Allergic rhinitis, rat, flavonoid






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.